Clinical Trial Results:
AN OPEN-LABEL, RANDOMIZED PROSPECTIVE STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF CAMPATH-1H AS AN INDUCTION AGENT IN COMBINATION WITH LOW DOSE-TACROLIMUS, LOW DOSE –MMF AND REDUCED STEROID THERAPY COMPARED TO ATG-INDUCTION IN COMBINATION WITH TACROLIMUS, MYCOPHENOLATE MOFETIL AND STEROIDS THERAPY
IN DE NOVO LUNG TRANSPLANTED PATIENTS
Summary
|
|
EudraCT number |
2007-001815-51 |
Trial protocol |
AT |
Global completion date |
21 Jul 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
31 May 2021
|
First version publication date |
31 May 2021
|
Other versions |
|
Summary report(s) |
Summary Attachment |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.